Aigen Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,680
Closed -$514K 742
2026
Q1
$514K Buy
8,680
+4,991
+135% +$324K 0.13% 205
2025
Q4
$228K Sell
3,689
-6,107
-62% -$374K 0.05% 442
2025
Q3
$611K Buy
9,796
+3,718
+61% +$259K 0.09% 339
2025
Q2
$485K Sell
6,078
-357
-6% -$29.9K 0.07% 406
2025
Q1
$553K Buy
+6,435
New +$528K 0.09% 327
2024
Q4
Sell
-4,785
Closed -$345K 936
2024
Q3
$345K Buy
+4,785
New +$339K 0.07% 425
2024
Q1
Sell
-3,873
Closed -$237K 926
2023
Q4
$237K Buy
+3,873
New +$230K 0.04% 596
2022
Q4
Sell
-14,879
Closed -$741K 711
2022
Q3
$741K Buy
+14,879
New +$824K 0.11% 241
2021
Q2
Sell
-20,319
Closed -$896K 669
2021
Q1
$896K Sell
20,319
-17,948
-47% -$754K 0.12% 196
2020
Q4
$1.33M Buy
+38,267
New +$1.36M 0.17% 153
2020
Q3
Sell
-5,448
Closed -$205K 1055
2020
Q2
$205K Buy
5,448
+960
+21% +$38.4K 0.03% 706
2020
Q1
$165K Buy
+4,488
New +$174K 0.02% 762

Other funds holding PBH

Aigen Investment Management's PBH Position: Q2 2026 in Review

Aigen Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 8,680 shares — an estimated $514K sold.

Aigen Investment Management first reported a position in PBH in Q1 2020 and held it in 12 quarters. The position peaked at $1.33M in Q4 2020. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Aigen Investment Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Aigen Investment Management sold 8,680 Prestige Consumer Healthcare shares in Q2 2026, an estimated $514K.
  • Aigen Investment Management first reported a position in Prestige Consumer Healthcare in Q1 2020 and held it in 12 quarters.
  • Aigen Investment Management's Prestige Consumer Healthcare position peaked at $1.33M in Q4 2020.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.